HOSPIPLAN
ActiveSummary
HOSPIPLAN has been active since 1996 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €5.2m and a net result of -€205,799. Equity remains stable across the filed financial years (±0.3% per year). Its solvency ranks better than 95% of 6,152 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Financials · financial year 2025, full format
Turnover
≈ €200,000
Estimated: probably between €100,000 and €270,000
EBIT margin
Not included in this filing
Net result
-€205,799
2024 · €566,554
Working capital
€1.1m▲ 4.7%
2024 · €1.1m
Trend over the years
2021 to 2025, 5 financial years 2019 to 2025, 7 financial years
The operating result falls in 2025; 2025 is 47% below 2024.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
Operating result€0.05m
2025
Net result-€0.2m
2025
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Total assets€5.3m
2025
Equity€5.2m
2025
Debt€0.08m
2025
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
Working capital€1.1m
2025
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
Return on assets (ROA)-3.9%
2025
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Solvency98.5%
2025
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Current ratio15.72
2025
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 46, Wholesale trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the financial year before
favourable
unfavourable
Line2019202020212022202320242025
Operating result€0.1m-€0.06m▼ 35.6%€0.05m▼ 13.4%€0.03m▼ 44.4%€0.06m▲ 91.0%€0.09m▲ 61.8%€0.05m▼ 47.2%
Net result-€0.2m--€0.1mbelow the sector's middle half▲ 52.6%-€0.04mbelow the sector's middle half▲ 63.3%-€0.03mbelow the sector's middle half▲ 15.5%€0.01mwithin the sector's middle half€0.6mwithin the sector's middle half▲ 38×-€0.2mbelow the sector's middle half
Equity€5.0m-€4.9mabove the sector's middle half▼ 2.1%€4.9mabove the sector's middle half▼ 0.8%€4.8mabove the sector's middle half▼ 0.7%€4.8mwithin the sector's middle half▲ 0.3%€5.4mabove the sector's middle half▲ 11.7%€5.2mwithin the sector's middle half▼ 3.8%
Total assets€5.2m-€5.0mwithin the sector's middle half▼ 4.3%€4.9mwithin the sector's middle half▼ 1.1%€4.9mwithin the sector's middle half▼ 0.3%€4.9mwithin the sector's middle half▲ 1.3%€5.6mwithin the sector's middle half▲ 12.7%€5.3mwithin the sector's middle half▼ 5.1%
Debt€0.2m-€0.04m▼ 72.1%€0.03m▼ 31.2%€0.05m▲ 65.2%€0.1m▲ 93.2%€0.2m▲ 63.3%€0.08m▼ 50.7%
Working capital€0.9m-€0.9mwithin the sector's middle half▲ 4.5%€1.0mwithin the sector's middle half▲ 5.0%€1.0mwithin the sector's middle half▲ 1.2%€1.0mwithin the sector's middle half▲ 4.3%€1.1mwithin the sector's middle half▲ 6.7%€1.1mwithin the sector's middle half▲ 4.7%
Solvency96.9%-99.1%above the sector's middle half▲ 2.2pp99.4%above the sector's middle half▲ 0.3pp99.0%above the sector's middle half▼ 0.4pp98.0%above the sector's middle half▼ 0.9pp97.2%above the sector's middle half▼ 0.9pp98.5%above the sector's middle half▲ 1.4pp
Current ratio6.60-21.99above the sector's middle half▲ 15.3833.05above the sector's middle half▲ 11.0720.64above the sector's middle half▼ 12.4211.60above the sector's middle half▼ 9.047.92above the sector's middle half▼ 3.6715.72above the sector's middle half▲ 7.80
Return on assets (ROA)-4.4%--2.2%below the sector's middle half▲ 2.2pp-0.8%below the sector's middle half▲ 1.4pp-0.7%below the sector's middle half▲ 0.1pp0.3%within the sector's middle half▲ 1.0pp10.2%above the sector's middle half▲ 9.9pp-3.9%below the sector's middle half▼ 14.1pp
above
within
below
the middle half of NACE 46, Wholesale trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €5.3m
Fixed assets
€4.1m ▼ 6.0%
Current assets
€1.2m ▼ 2.3%
Equity and liabilities €5.3m
Equity
€5.2m ▼ 3.8%
Debt
€77,720 ▼ 50.7%
Debt's share of the balance-sheet total falls from 2.8% to 1.5%. Equity and debt are lower.
Key figures and ratios
Quick ratio
14.49▲
2024 · 7.38
Debt to equity
0.01▼
2024 · 0.03
ROE
-4.0%▼
2024 · 10.5%
Debt ≤ 1 year
€77,720▼
2024 · €157,761
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Other operating charges640/8 | - | - | - | €868 | €1,074 | €1,060 | €1,020 | ▼ 3.8% |
| Gross operating margin9900 | €98,625 | €63,803 | €55,387 | €31,175 | €58,966 | €94,701 | €50,493 | ▼ 46.7% |
| Operating profit (loss)9901 | €97,757 | €62,935 | €54,519 | €30,307 | €57,893 | €93,642 | €49,473 | ▼ 47.2% |
| Financial income75/76B | - | - | - | - | - | €498,767 | €2,541 | ▼ 99.5% |
| Recurring financial income75 | €160 | €21 | - | - | - | €1,214 | €2,541 | ▲ 109% |
| Non-recurring financial income76B | - | - | - | - | - | €497,553 | - | - |
| Financial charges65/66B | - | - | - | €46,099 | €27,895 | €620 | €257,813 | ▲ 416× |
| Recurring financial charges65 | €1,939 | €1,119 | €805 | €1,034 | €689 | €620 | €424 | ▼ 31.6% |
| Non-recurring financial charges66B | - | - | - | €45,065 | €27,206 | - | €257,389 | - |
| Profit (loss) for the period before taxes9903 | -€193,870 | -€84,719 | -€31,974 | -€15,791 | €29,997 | €591,789 | -€205,799 | - |
| Income taxes67/77 | €31,642 | €22,214 | €7,238 | €17,325 | €15,266 | €25,235 | - | - |
| Profit (loss) for the period9904 | -€225,512 | -€106,933 | -€39,212 | -€33,116 | €14,731 | €566,554 | -€205,799 | - |
| Profit (loss) for the period to be appropriated9905 | -€225,512 | -€106,933 | -€39,212 | -€33,116 | €14,731 | €566,554 | -€205,799 | - |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total assets20/58 | €5.2m | €5.0m | €4.9m | €4.9m | €4.9m | €5.6m | €5.3m | ▼ 5.1% |
| Fixed assets21/28 | €4.1m | €4.0m | €3.9m | €3.9m | €3.8m | €4.3m | €4.1m | ▼ 6.0% |
| Financial fixed assets28 | €4.1m | €4.0m | €3.9m | €3.9m | €3.8m | €4.3m | €4.1m | ▼ 6.0% |
| Current assets29/58 | €1.0m | €1.0m | €1.0m | €1.0m | €1.1m | €1.3m | €1.2m | ▼ 2.3% |
| Stocks and contracts in progress3 | €0.2m | €0.1m | €0.1m | €0.09m | €0.06m | €0.09m | €0.1m | ▲ 12.0% |
| Stocks30/36 | - | - | - | €0.09m | €0.06m | €0.09m | €0.1m | ▲ 12.0% |
| Amounts receivable within one year40/41 | €0.4m | €0.4m | €0.5m | €0.6m | €0.6m | €0.7m | €0.7m | ▼ 1.2% |
| Trade receivables40 | - | - | - | €0.4m | €0.3m | €0.3m | €0.3m | ▼ 15.2% |
| Other amounts receivable41 | - | - | - | €0.2m | €0.3m | €0.4m | €0.4m | ▲ 10.9% |
| Current investments50/53 | €0.2m | €0.2m | €0.2m | €0.2m | €0.2m | €0.2m | €0.2m | ▲ 1.2% |
| Cash at bank and in hand54/58 | €0.3m | €0.3m | €0.3m | €0.2m | €0.3m | €0.3m | €0.3m | ▼ 10.5% |
| Deferred charges and accrued income490/1 | - | - | - | €314 | €314 | €314 | €314 | = |
| Equity and liabilities | ||||||||
| Total equity and liabilities10/49 | €5.2m | €5.0m | €4.9m | €4.9m | €4.9m | €5.6m | €5.3m | ▼ 5.1% |
| Equity10/15 | €5.0m | €4.9m | €4.9m | €4.8m | €4.8m | €5.4m | €5.2m | ▼ 3.8% |
| Contributions10/11 | €6.5m | - | - | €6.5m | €6.5m | €6.5m | €6.5m | = |
| Reserves13 | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | = |
| Non-distributable reserves130/1 | - | - | - | €0.3m | €0.3m | - | - | - |
| Reserves not available under the articles1311 | - | - | - | €0.3m | €0.3m | - | - | - |
| Distributable reserves133 | - | - | - | - | - | €0.3m | €0.3m | = |
| Profit (loss) carried forward14 | -€1.8m | -€1.9m | -€1.9m | -€1.9m | -€1.9m | -€1.4m | -€1.6m | ▼ 15.2% |
| Amounts payable17/49 | €0.2m | €0.04m | €0.03m | €0.05m | €0.1m | €0.2m | €0.08m | ▼ 50.7% |
| Amounts payable within one year42/48 | €0.2m | €0.04m | €0.03m | €0.05m | €0.1m | €0.2m | €0.08m | ▼ 50.7% |
| Trade debts44 | €0.1m | €0.02m | €0.02m | €0.03m | €0.08m | €0.1m | €0.07m | ▼ 43.9% |
| Suppliers440/4 | - | - | - | €0.03m | €0.08m | €0.1m | €0.07m | ▼ 43.9% |
| Taxes, remuneration and social security45 | - | - | - | €0.02m | €0.02m | €0.03m | €0.007m | ▼ 77.5% |
| Taxes450/3 | - | - | - | €0.02m | €0.02m | €0.03m | €0.007m | ▼ 77.5% |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€225,512 | -€106,933 | -€39,212 | -€33,116 | €14,731 | €566,554 | -€205,799 | - |
| Operating cash flow (approximation) | -€225,512 | -€106,933 | -€39,212 | -€33,116 | €14,731 | €566,554 | -€205,799 | - |
| Investment in fixed assets (approximation) | - | €146,556 | €85,687 | €45,065 | €27,206 | -€497,553 | €257,389 | - |
| Change in cash | - | €72,170 | -€44,434 | -€37,689 | €57,629 | €2,224 | -€31,755 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Latest 10 of 28 filings with the National Bank
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 30-06-2025 | full format | 12-12-2025 | 2025-00580381 |
| 30-06-2024 | full format | 31-12-2024 | 2024-00627725 |
| 30-06-2023 | full format | 15-12-2023 | 2023-00528474 |
| 30-06-2022 | full format | 29-12-2022 | 2022-20548631 |
| 30-06-2021 | full format | 07-01-2022 | 2022-00400294 |
| 30-06-2020 | full format | 29-01-2021 | 2021-02400473 |
| 30-06-2019 | full format | 22-01-2020 | 2020-01800081 |
| 30-06-2018 | full format | 18-01-2019 | 2019-01600426 |
| 30-06-2017 | full format | 23-01-2018 | 2018-01900187 |
| 30-06-2016 | full format | 09-01-2017 | 2017-00400396 |
Similar companies · same sector, comparable size
KEYPHARM
BE 0883.397.311
Oostkamp · equity €5,202,102
EDWARDS LIFESCIENCES BELGIUM
BE 0469.903.830
Vilvoorde · equity €5,274,461
APEX
BE 0871.977.342
Braine-l'Alleud · equity €5,137,280
COCHLEAR BENELUX
BE 0439.545.206
Mechelen · equity €5,295,570
GRUNENTHAL
BE 0403.085.874
Zaventem · equity €5,122,762
Of the 1,866 active companies whose main activity is wholesale of pharmaceutical and medical goods (NACE 46460), figures are known for 1,128. 562 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.